Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3217]

EHA 2019: Labor is the most frequent outcome in the European Leukemia Net registry of patients with chronic myeloid leukaemia and pregnancy

EHA 2019: Labor is the most frequent outcome in the European Leukemia Net registry of patients with chronic...

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously untreated patients with chronic lymphocytic leukaemia and coexisting comorbidities

EHA 2019: Introduction of a new fixed-duration targeted therapy with venetoclax plus obinutuzumab in previously...

A heart failure drug to treat leukaemia: a promising new therapeutic approach

A heart failure drug to treat leukaemia: a promising new therapeutic approach

SIRT1 plays key role in chronic myeloid leukemia to aid persistence of leukemic stem cells

SIRT1 plays key role in chronic myeloid leukemia to aid persistence of leukemic stem cells

FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma

FDA approves polatuzumab vedotin-piiq for diffuse large B-cell lymphoma

Walking speed points to future clinical outcomes for older patients with blood cancers

Walking speed points to future clinical outcomes for older patients with blood cancers

Immunotherapy drug found safe in treating cancer patients with HIV

Immunotherapy drug found safe in treating cancer patients with HIV

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: NCI-MATCH trial finds the combination of dabrafenib and trametinib effective

ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma

ASCO 2019: Cleveland researchers test novel gene therapy for glioblastoma

FDA approves lenalidomide for follicular and marginal zone lymphoma

FDA approves lenalidomide for follicular and marginal zone lymphoma

More from ecancer